Bone Biologics Co. (NASDAQ:BBLGW – Get Free Report)’s stock price rose 2.2% during mid-day trading on Friday . The company traded as high as $16.06 and last traded at $15.50. Approximately 4 shares changed hands during trading, a decline of 100% from the average daily volume of 1,370 shares. The stock had previously closed at $15.16.
Bone Biologics Stock Performance
The stock has a 50 day moving average price of $17.61 and a two-hundred day moving average price of $14.22.
Bone Biologics Company Profile
Bone Biologics, Inc is a clinical-stage biopharmaceutical company focused on developing protein-based therapeutics designed to promote bone healing and regeneration in acute and chronic orthopedic conditions. Its proprietary platform combines key osteogenic growth factors with engineered delivery matrices to support repair in complex fractures, spinal fusion procedures and non-union bone injuries. By targeting the biology of bone formation, the company aims to overcome limitations associated with autografts, allografts and synthetic implants.
The company’s lead candidate is advancing through preclinical evaluation, with studies assessing efficacy in animal models of fracture repair and spinal arthrodesis.
Recommended Stories
- Five stocks we like better than Bone Biologics
- Do not delete, read immediately
- The $100 Trillion AI Story No One Is Telling You
- If You Keep Cash In A U.S. Bank Account… Read This NOW
- But this $2 Gold Stock Before May 20, 2026
- 3 Overlooked Deductions to Help Potentially Minimize Capital Gains Tax
Receive News & Ratings for Bone Biologics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bone Biologics and related companies with MarketBeat.com's FREE daily email newsletter.
